EntrepreneurialCheck
MILAD RIAZIFAR estimated net worth profile

MILAD RIAZIFAR net worth

MILAD RIAZIFAR Net Worth 2026 (Estimated) · Founder at Entelexo Biotherapeutics · YC W21
est. wealth $6.67M

Quick answer

MILAD RIAZIFAR's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. MILAD RIAZIFAR is Founder at Entelexo Biotherapeutics. Entelexo Biotherapeutics valuation.

MILAD RIAZIFAR is Founder at Entelexo Biotherapeutics (YC W21). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameMILAD RIAZIFAR
RoleFounder
CompanyEntelexo Biotherapeutics
YC batchW21
Est. company val$20.0M
Assumed ownership33.3%
Est. paper wealth / net worth$6.67M
$4.67M – $10.0M
  • Company status: Active
  • Education: PhD in Bioengineering from the University of Southern California
  • Region: United States of America
  • Industries: Healthcare, Therapeutics
  • Team size: 3
  • Website: https://www.entelexo.com/

Who is MILAD RIAZIFAR?

Milad Riazifar is a founder at Entelexo Biotherapeutics, a startup that focuses on innovative biotherapeutics.

Highlights:

  • Stanford University
  • University of Southern California
  • Part of Y Combinator W21 batch

About Entelexo Biotherapeutics

Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.

FAQ: MILAD RIAZIFAR net worth and Entelexo Biotherapeutics valuation

What is MILAD RIAZIFAR's net worth?

MILAD RIAZIFAR's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. MILAD RIAZIFAR is Founder at Entelexo Biotherapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Entelexo Biotherapeutics valuation?

Entelexo Biotherapeutics's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is MILAD RIAZIFAR's role?

MILAD RIAZIFAR is Founder at Entelexo Biotherapeutics, a Y Combinator-backed startup (batch W21).